Corbevax for Children Aged 12-14 Years: How Does it Work? What's the Dosage?

Experts from India's central drug authority recommended on Monday that Corbevax COVID-19 vaccine be granted EUA for administration in children.

(Photo: The Quint)

COVID-19 vaccination for children aged 12-14 will begin from 16 March, Union Health Minister Mansukh Mandaviya said. The National Technical Advisory Group on Immunisation (NTAGI) recommended Biological E's Corbevax vaccine to be administered to the 12-14 year age group, news agency PTI reported.

How is it different? What is its dosage? Here is all you need to know:

For which age group is Corbevax recommended?

Corbevax is recommended for administration in children aged 12 to 18 years. On 21 February, the Drugs Controller General of India (DCGI) granted final approval to Biological E's Corbevax for children between 12 and 18 years of age.

Is Corbevax now available for children?

The COVID-19 vaccine to be administered for children between 12 and 14 would be Corbevax manufactured by Biological Evans in Hyderabad.

When was it approved for adults?

Corbevax has already been approved by the DCGI on 28 December 2021 for usage in adults.

The manufacturers of Corbevax have already conducted phase 1/2 and 2/3 trials in India.

What is the dosage of Corbevax?

The dosage for Corbevax is:

• A double-dose vaccine

• Administered 28 days apart

• Of 0.5ml quantity in a single dose

What kind of COVID-19 vaccine is it?

Corbevax COVID vaccine is:

• An RBD protein sub-unit vaccine

• First of its kind to be indigenously developed in India

• An intramuscular vaccine

• Stored at 2-8 degree Celsius

When will children below the age of 12 be vaccinated?

There is no information on this. Watch out this space for more information.